We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

In Victory For Teva, Federal Circuit Sends Accupril Patent Suit Back To New Jersey

Law360 (August 11, 2005, 12:00 AM EDT) -- The U.S. Court of Appeals for the Federal Circuit has ruled in favor of Israeli generics maker Teva Pharmaceuticals in a lawsuit brought by Pfizer Inc., asking a New Jersey federal court to review a decision that halted sales of a generic version of the hypertension drug Accupril.

The appeals court upheld a ruling by the U.S. District Court for the District of New Jersey that the disputed patent is not unenforceable by reason of inequitable conduct.

However, the court noted that “there are genuine issues...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.